From: RPL35A promotes the progression of cholangiocarcinoma by mediating HSPA8 ubiquitination
Features | No. of patients | RPL35A expression | P value | |
---|---|---|---|---|
low | high | |||
All patients | 88 | 37 | 51 | Â |
Age (years) | Â | Â | Â | 0.080 |
< 61 | 43 | 14 | 29 |  |
≥ 61 | 45 | 23 | 22 |  |
Gender | Â | Â | Â | 0.042* |
Male | 56 | 19 | 37 | Â |
Female | 32 | 18 | 14 | Â |
Grade | Â | Â | Â | 0.693 |
I | 1 | 1 | 0 | Â |
II | 49 | 19 | 30 | Â |
III | 37 | 16 | 21 | Â |
IV | 1 | 1 | 0 | Â |
Tumor size |  |  |  | 0.830 |
< 6.5 cm | 44 | 18 | 26 |  |
≥ 6.5 cm | 44 | 19 | 25 |  |
Metastasis | Â | Â | Â | 0.743 |
M0 | 84 | 35 | 49 | Â |
M1 | 4 | 2 | 2 | Â |